Medical Devices — Sales to customers (Note 9)
Business Segments · Sales to customers (Note 9)Johnson & Johnson Medical Devices — Sales to customers (Note 9) decreased by 1.3% to $8.43B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 6.8%, from $7.89B to $8.43B. Over 3 years (FY 2021 to FY 2024), Medical Devices — Sales to customers (Note 9) shows an upward trend with a 11.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2013
Last reportedQ3 2025
Rolls up toTotal Revenue
How to read this metric
Higher sales indicate strong market adoption and successful commercial execution.
Detailed definition
Represents the total revenue generated from the sale of medical devices and related services to external customers. This...
Peer comparison
The standard revenue metric for all public companies.
Metric ID:
jnj_segment_medtech_sales_to_customers_note_9Historical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.58B | $6.98B | $6.64B | $6.78B | $6.97B | $6.90B | $6.78B | $7.46B | $7.48B | $7.79B | $7.67B | $7.82B | $7.96B | $7.89B | $8.19B | $8.02B | $8.54B | $8.43B |
| QoQ Change | — | +6.1% | -4.8% | +2.0% | +2.9% | -1.0% | -1.7% | +10.0% | +0.3% | +4.1% | -1.5% | +1.9% | +1.7% | -0.8% | +3.8% | -2.1% | +6.5% | -1.3% |
| YoY Change | — | — | — | — | +6.0% | -1.1% | +2.1% | +10.1% | +7.3% | +12.9% | +13.1% | +4.9% | +6.4% | +1.3% | +6.7% | +2.5% | +7.3% | +6.8% |
Range$6.58B – $8.54B
CAGR+6.0%
Avg YoY Growth+6.2%
Median YoY Growth+6.5%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's medical devices — sales to customers (note 9)?
- Johnson & Johnson (JNJ) reported medical devices — sales to customers (note 9) of $8.43B in Q3 2025.
- How has Johnson & Johnson's medical devices — sales to customers (note 9) changed year-over-year?
- Johnson & Johnson's medical devices — sales to customers (note 9) increased by 6.8% year-over-year, from $7.89B to $8.43B.
- What is the long-term trend for Johnson & Johnson's medical devices — sales to customers (note 9)?
- Over 3 years (2021 to 2024), Johnson & Johnson's medical devices — sales to customers (note 9) has grown at a 11.5% compound annual growth rate (CAGR), from $22.96B to $31.86B.
- What does medical devices — sales to customers (note 9) mean?
- The total revenue earned from selling medical devices to customers.